Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
Directly observed therapy for HCV successful even at extended intervals among PWIDs
BOSTON — Use of directly observed therapy was successful even at extended intervals when treating hepatitis C virus infection among people who inject drugs, according to research presented at The Liver Meeting.
Sofosbuvir/velpatasvir with ribavirin improves liver, renal function in chronic HCV
BOSTON — A regimen of sofosbuvir/velpatasvir with ribavirin was effective among patients with refractory chronic hepatitis C virus with liver cirrhosis and chronic kidney disease, according to data presented at The Liver Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
National virtual HCV program expands access to care for children, adolescents in the UK
BOSTON — A virtual treatment program that coordinates care with local providers improved therapy for children and adolescents with hepatitis C virus in the United Kingdom, according to a presentation at The Liver Meeting.
Universal HCV screening, linkage to care 'effective’ cancer prevention strategy
BOSTON — Implementation of universal hepatitis C virus screening at cancer centers and corresponding care may positively affect HCV elimination targets and improve public health outcomes, according to a presentation at The Liver Meeting.
Syringe sharing reduced among PWID with improved access to methadone providers
BOSTON — There is a reduction in syringe sharing when methadone providers are spread out near areas with the greatest density of people who inject drugs, according to research presented at The Liver Meeting.
VIDEO: Treatment for hepatitis C virus infection still low among patients with HCC
BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses data from The Liver Meeting on treatment of hepatitis C virus infection among individuals with hepatocellular carcinoma.
Liver transplant rates for HCC decline across all races after 2015 MELD policy change
Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.
VIDEO: ‘Unique’ protocol expands transplant pool to include HCV-infected donors
BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, spoke with Healio about a presentation from The Liver Meeting on “The Toronto Protocol,” an ultra-short course of glecaprevir/pibrentasvir with ezetimibe.
VIDEO: Prevalence of HCV has not changed since 2013-2016 estimate
BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses findings from an abstract at The Liver Meeting, which estimated the prevalence of hepatitis C virus infection in the United States between 2017 and 2020.
VIDEO: Treating HCV in pregnancy may reduce risk for mother-to-child transmission
BOSTON — Healio spoke with Norah Terrault, MD, MPH, FAASLD, about presentations from The Liver Meeting that investigated testing and treatment of hepatitis C virus infection among pregnant individuals.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read